News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
451,914 Results
Type
Article (23114)
Company Profile (155)
Press Release (428645)
Section
Business (143387)
Career Advice (1306)
Deals (25684)
Drug Delivery (103)
Drug Development (54127)
Employer Resources (90)
FDA (9906)
Job Trends (10988)
News (239228)
Policy (22998)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (3)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (2)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1360)
Accelerated approval (1)
Adcomms (21)
Allergies (51)
Alliances (38493)
ALS (54)
Alzheimer's disease (772)
Antibody-drug conjugate (ADC) (89)
Approvals (9920)
Artificial intelligence (177)
Autoimmune disease (11)
Automation (7)
Bankruptcy (235)
Best Places to Work (8430)
BIOSECURE Act (16)
Biosimilars (97)
Biotechnology (69)
Bladder cancer (33)
Brain cancer (19)
Breast cancer (135)
Cancer (1228)
Cardiovascular disease (115)
Career advice (1069)
Career pathing (22)
CAR-T (63)
Cell therapy (199)
Cervical cancer (10)
Clinical research (45000)
Collaboration (557)
Compensation (296)
Complete response letters (22)
COVID-19 (1489)
CRISPR (25)
C-suite (156)
Cystic fibrosis (59)
Data (1212)
Decentralized trials (2)
Denatured (20)
Depression (26)
Diabetes (154)
Diagnostics (4074)
Digital health (11)
Diversity (9)
Diversity, equity & inclusion (23)
Drug discovery (81)
Drug pricing (115)
Drug shortages (31)
Duchenne muscular dystrophy (57)
Earnings (52615)
Editorial (32)
Employer branding (10)
Employer resources (82)
Events (63424)
Executive appointments (499)
FDA (10622)
Featured Employer (27)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (400)
Gene editing (53)
Generative AI (19)
Gene therapy (165)
GLP-1 (604)
Government (3240)
Grass and pollen (4)
Guidances (32)
Healthcare (11981)
Huntington's disease (13)
IgA nephropathy (18)
Immunology and inflammation (82)
Indications (20)
Infectious disease (1590)
Inflammatory bowel disease (90)
Inflation Reduction Act (8)
Influenza (33)
Intellectual property (61)
Interviews (194)
IPO (10580)
IRA (47)
Job creations (2857)
Job search strategy (940)
Kidney cancer (7)
Labor market (23)
Layoffs (311)
Leadership (14)
Legal (5273)
Liver cancer (37)
Lung cancer (175)
Lymphoma (95)
Machine learning (2)
Management (34)
Manufacturing (228)
MASH (47)
Medical device (6156)
Medtech (6159)
Mergers & acquisitions (15458)
Metabolic disorders (502)
Multiple sclerosis (51)
NASH (20)
Neurodegenerative disease (49)
Neuropsychiatric disorders (21)
Neuroscience (1085)
NextGen: Class of 2025 (4488)
Non-profit (2792)
Northern California (1309)
Now hiring (21)
Obesity (303)
Opinion (204)
Ovarian cancer (39)
Pain (67)
Pancreatic cancer (44)
Parkinson's disease (84)
Partnered (14)
Patents (142)
Patient recruitment (54)
Peanut (23)
People (43813)
Pharmaceutical (78)
Pharmacy benefit managers (21)
Phase I (13996)
Phase II (19213)
Phase III (15239)
Pipeline (757)
Podcasts (72)
Policy (116)
Postmarket research (1733)
Preclinical (5007)
Press Release (70)
Prostate cancer (69)
Psychedelics (23)
Radiopharmaceuticals (183)
Rare diseases (251)
Real estate (4719)
Recruiting (34)
Regulatory (15898)
Reports (23)
Research institute (1265)
Resumes & cover letters (207)
Rett syndrome (1)
RNA editing (1)
RSV (26)
Schizophrenia (59)
Series A (61)
Series B (38)
Service/supplier (16)
Sickle cell disease (40)
Southern California (1234)
Special edition (16)
Spinal muscular atrophy (117)
Sponsored (21)
Startups (2432)
State (2)
Stomach cancer (9)
Supply chain (56)
The Weekly (49)
United States (12800)
Vaccines (321)
Venture capitalists (27)
Webinars (11)
Weight loss (241)
Women's health (21)
Worklife (9)
Date
Today (18)
Last 7 days (365)
Last 30 days (1622)
Last 365 days (21844)
2025 (5119)
2024 (22799)
2023 (25785)
2022 (34443)
2021 (36716)
2020 (36531)
2019 (32853)
2018 (25150)
2017 (22468)
2016 (21443)
2015 (24716)
2014 (19159)
2013 (16203)
2012 (17502)
2011 (18139)
2010 (16560)
Location
Africa (530)
Alabama (30)
Alaska (5)
Arizona (106)
Arkansas (10)
Asia (29474)
Australia (3890)
California (3092)
Canada (1438)
China (350)
Colorado (160)
Connecticut (157)
Delaware (85)
Europe (62984)
Florida (518)
Georgia (88)
Hawaii (1)
Idaho (32)
Illinois (368)
India (20)
Indiana (219)
Iowa (5)
Japan (114)
Kansas (74)
Kentucky (21)
Louisiana (5)
Maine (27)
Maryland (578)
Massachusetts (2429)
Michigan (108)
Minnesota (189)
Mississippi (2)
Missouri (44)
Montana (18)
Nebraska (16)
Nevada (31)
New Hampshire (28)
New Jersey (1170)
New Mexico (24)
New York (861)
North Carolina (669)
North Dakota (5)
Northern California (1309)
Ohio (139)
Oklahoma (10)
Oregon (24)
Pennsylvania (773)
Puerto Rico (10)
Rhode Island (18)
South America (790)
South Carolina (5)
Southern California (1234)
Tennessee (67)
Texas (476)
Utah (76)
Virginia (103)
Washington D.C. (52)
Washington State (270)
West Virginia (3)
Wisconsin (33)
451,914 Results for "pci pharma services lsne".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Aldena Therapeutics Selects PCI Pharma Services to Manufacture and Distribute Innovative Investigational Treatment for Dermatological Diseases
Aldena Therapeutics has chosen PCI Pharma Services, a world-leading global contract development and manufacturing organization to formulate, package, and distribute ALD-102, an siRNA-based investigational injectable treatment for inflammatory dermatological conditions, all under one roof at PCI’s San Diego facility.
October 19, 2023
·
4 min read
Deals
PCI Pharma Services Announces the Closing of Its Acquisition of LSNE
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced the closing of the previously announced acquisition of Lyophilization Services of New England, Inc. (LSNE), a premier contract development and manufacturing organization headquartered in Bedford, New Hampshire.
December 14, 2021
·
2 min read
Press Releases
PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products
September 24, 2024
·
5 min read
Press Releases
PCI Biotech full year 2024 interim results
February 27, 2025
·
4 min read
Press Releases
PCI Biotech: Invitation to preliminary full-year 2024 results presentation
February 25, 2025
·
1 min read
Deals
PCI Pharma Services Announces the Acquisition of LSNE to Add End-To-End Global Sterile Fill-Finish and Lyophilization Manufacturing Capabilities
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global integrated solutions provider, announced it has signed a definitive agreement to acquire Lyophilization Services of New England, Inc. (LSNE), a premier contract development and manufacturing organization (CDMO) headquartered in Bedford, New Hampshire, from global private equity firm Permira.
October 12, 2021
·
3 min read
Clinical research
Pharma R&D Returns Grow Again, But Deloitte Warns Progress is ‘Fragile’
Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.
March 27, 2025
·
3 min read
·
Annalee Armstrong
Pharm Country
Following LSNE Acquisition, PCI Pharma Services Continues to Expand Sterile Fill-Finish Expertise with State-of-the-Art Equipment
PCI Pharma Services, a leading global contract development and manufacturing organization, announced the addition of three new exceptional automated sterile fill-finish machines in its San Diego and Melbourne facilities.
February 2, 2022
·
4 min read
Pharm Country
PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego
PCI Pharma Services, a leading global contract development and manufacturing organization, announced that three new state-of-the-art automated sterile fill-finish machines at its San Diego and Melbourne facilities are now fully operational.
April 18, 2023
·
4 min read
Government
Trump Threatens Big Pharma With Tariffs—Unless They Reshore Manufacturing: Bloomberg
President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.
February 24, 2025
·
2 min read
·
Tristan Manalac
1 of 45,192
Next
